DENMARK – Novo Nordisk, a Danish pharmaceutical company, has agreed to buy Dicerna Pharmaceuticals for US$3.3 billion in cash, the company has announced. Dicerna Pharmaceuticals creates RNAi-based therapies that selectively…
Read MoreDenmark’s Novo Nordisk reaches US$3.3 billion deal to acquire Dicerna Pharma
